Vera Therapeutics, Inc.
VERA
DELAYED 1 MONTH

11 insider filings · Latest: May 21, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 12, 2026May 13 8:26 PMMarshall FordyceDirector, PRESIDENT AND CEO
Sale
18,500$36.74$679.7K216,744(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 21, 2026May 26 8:24 PMScott W MorrisonDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:22 PMAndrew ChengDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:22 PMBeth C SeidenbergDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:20 PMChristy J. OligerDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:19 PMJames R MeyersDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:18 PMKimball HallDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:17 PMMichael MorrisseyDirector
Grant/Award
17,084$34.3517,084(D)

View →

May 21, 2026May 26 8:15 PMPatrick G EnrightDirector
Grant/Award
17,084$34.3517,084(D)

View →

Mar 13, 2026Mar 16 10:52 PMJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR
Option Exercise
10,000$3.9438,589(D)

View →

Mar 5, 2026Mar 9 8:49 PMChristopher HiteDirector
Grant/Award
24,937$38.8524,937(D)

View →